Filing Details
- Accession Number:
- 0001367644-21-000051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-08 18:30:56
- Reporting Period:
- 2021-03-04
- Accepted Time:
- 2021-03-08 18:30:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1403769 | Sue Bailey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-04 | 8,168 | $92.37 | 24,427 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
- These shares are held of record by a living trust, for which the Reporting Person serves as Trustee.
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $91.01 to $93.50.